Stocks rose sharply Monday after the U.S. and China said they had reached an agreement over the weekend to temporarily slash ...

Injected weight-loss drugs Wegovy, from Novo Nordisk, and Eli Lilly's Zepbound have U.S. list prices of over $1,000 a month.

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in ...

CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.